Two Sigma Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$382K Buy
+403,922
New +$382K ﹤0.01% 2647
2024
Q4
Sell
-204,879
Closed -$322K 3301
2024
Q3
$322K Buy
204,879
+185,723
+970% +$292K ﹤0.01% 2586
2024
Q2
$32.2K Sell
19,156
-170,275
-90% -$286K ﹤0.01% 2831
2024
Q1
$455K Sell
189,431
-13,456
-7% -$32.3K ﹤0.01% 2317
2023
Q4
$310K Sell
202,887
-442,481
-69% -$677K ﹤0.01% 2599
2023
Q3
$703K Buy
645,368
+517,726
+406% +$564K ﹤0.01% 2055
2023
Q2
$292K Buy
+127,642
New +$292K ﹤0.01% 2445
2023
Q1
Sell
-115,231
Closed -$220K 3023
2022
Q4
$220K Buy
115,231
+71,934
+166% +$137K ﹤0.01% 2301
2022
Q3
$104K Buy
+43,297
New +$104K ﹤0.01% 2176
2021
Q3
Sell
-292,896
Closed -$1.34M 2782
2021
Q2
$1.34M Sell
292,896
-177,442
-38% -$814K ﹤0.01% 1547
2021
Q1
$2.76M Buy
+470,338
New +$2.76M 0.01% 1108
2020
Q3
Sell
-194,058
Closed -$387K 2158
2020
Q2
$387K Sell
194,058
-178,159
-48% -$355K ﹤0.01% 1528
2020
Q1
$726K Sell
372,217
-618,202
-62% -$1.21M 0.01% 1108
2019
Q4
$4.11M Buy
990,419
+866,040
+696% +$3.59M 0.01% 814
2019
Q3
$374K Buy
124,379
+10,739
+9% +$32.3K ﹤0.01% 1555
2019
Q2
$715K Sell
113,640
-1,532
-1% -$9.64K ﹤0.01% 1475
2019
Q1
$640K Sell
115,172
-198,705
-63% -$1.1M ﹤0.01% 1572
2018
Q4
$2.08M Buy
313,877
+129,215
+70% +$858K 0.01% 1030
2018
Q3
$1.97M Sell
184,662
-76,671
-29% -$818K 0.01% 1105
2018
Q2
$3.14M Buy
261,333
+77,660
+42% +$932K 0.01% 906
2018
Q1
$1.57M Buy
183,673
+7,452
+4% +$63.9K 0.01% 1146
2017
Q4
$1.74M Buy
176,221
+63,672
+57% +$629K 0.01% 1211
2017
Q3
$1.38M Buy
112,549
+26,871
+31% +$330K ﹤0.01% 1158
2017
Q2
$1.41M Buy
+85,678
New +$1.41M 0.01% 1220
2016
Q4
Sell
-283,651
Closed -$5.13M 2308
2016
Q3
$5.13M Buy
+283,651
New +$5.13M 0.02% 662
2015
Q1
Sell
-57,812
Closed -$368K 2262
2014
Q4
$368K Buy
+57,812
New +$368K ﹤0.01% 1851
2014
Q1
Sell
-5,390
Closed -$68K 2149
2013
Q4
$68K Buy
+5,390
New +$68K ﹤0.01% 2106